Actinium Pharmaceuticals, Inc.

Actinium Pharmaceuticals, Inc. (ATNM) — Form 4: Insider transaction

4ATNMFiled Oct 16, 2026, 1:11 PM ET· Period Oct 14, 2026

About this filing

Actinium Pharmaceuticals, Inc. (ATNM) filed Form 4 (insider transaction) with the SEC on Oct 16, 2026. Form 4 reports a company insider’s trades in the company’s shares.

View original filing on SEC.gov

Key facts

Key facts aren’t available for this filing right now. The original on SEC.gov has the full filing.

More ATNM filings

3
Initial insider holdings
Filed Oct 16, 2026
ARS
SEC filing
Filed Oct 16, 2026
DEF 14A
Proxy statement
Filed Oct 16, 2026
8-K
Current report
Filed Oct 15, 2026
S-8
SEC filing
Filed Oct 9, 2026
3
Initial insider holdings
Filed Sep 10, 2026

Not investment advice. Summaries can contain errors; the SEC filing is the official record.